gastroscopy and improvements in immunohistological techniques.
Introduction
Gastric carcinoid tumors had been considered to be rare, accounting for about 0.3% of all gastric tumors and fewer than 2% of all carcinoid tumors [1, 2] . Recently, however, the number of reports of gastric carcinoid tumors has increased, with the widespread use of consisted of a poorly differentiated adenocarcinoma confined to the mucosal layer (Fig. 2B) , and the small elevated lesion, which was 5 mm in diameter, corresponded to a carcinoid tumor, confined to the submucosal layer, and was characterized by small, microlobular-trabecular aggregates formed by regularly distributed regular monomorphic nuclei (Fig. 2C,D) . Immunohistological staining of the carcinoid tumor revealed that it was positive for Grimelius silver and chromogranin. The regional lymph node along the lesser curvature, number 3 according to the Nclassification of the Japanese Research Society for Gastric Cancer [8] , showed metastasis from the carcinoid tumor (Fig. 2E) . No recurrence or metastasis of the carcinoid tumor or adenocarcinoma has been detected during 6 years of follow-up.
Discussion
Gastric carcinoid tumors had been regarded as rare and benign [1, 2] . However, with the widespread use of endoscopy and improvements in immunohistological techniques, recent studies have demonstrated that carcinoid tumors may account for large a proportion as 27.3%-41% of all gastrointestinal endocrine tumors [9] [10] [11] .
According to Rindi et al. [3] [4] [5] , gastric carcinoid tumors are classified into three types, on the basis of their clinicopathological features, the presence or absence of hypergastrinemia, and histological features suggesting a benign or low-grade malignant tumor, as follows. Type I includes carcinoid tumors associated with chronic atrophic corporal gastritis; type II includes carcinoid tumors associated with Zollinger-Ellison syndrome or multiple endocrine neoplasia type 1; and type III includes carcinoid tumors associated with sporadic and malignant characteristics without hypergastrinemia. Most gastric carcinoid tumors are mainly composed of enterochromaffin-like cells, and the behavior of any gastric carcinoid tumor depends on its size and depth [6, 7] .
In Western countries, types I, II, and III were reported to account for 79.6%-87.8%; 0-6.3%, and 11.3%-14.3% of gastric carcinoid tumors [3, 5, 11] , 
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respectively. The rates of regional lymph node metastases from types I, II, and III were reported to be 0-7.6%, 0-12%, and 16.7%-38.6% [3, 11] , respectively. According to the histology and biological behavior of carcinoid tumors, the decision tree of Gilligan et al. [12] recommends treatments for carcinoid tumors as follows: endoscopic excision followed by endoscopic surveillance for tumors of types I and II, with the requirement for aggressive surgery for type III.
On the other hand, in Japan, types I, II, and III were reported to account for 34.2%-58.2%, 0-8.3%, and 33.3%-50% of gastric carcinoid tumors [13, 14] , respectively. The rates of regional lymph node metastasis from types I, II, and III were 25%, 12%, and 35.7% [13] , showing a small elevated lesion with central depression, and nearby, a superficial depressed lesion. B-D Histologically, the depressed lesion consisted of a poorly differentiated adenocarcinoma confined to the mucosa (B), while the elevated tumor, which was 5 mm in diameter, corresponded to a typical carcinoid tumor, and was confined to the submucosa (C, D). E The lymph node showed the same histology as the carcinoid tumor, confirming that it was a metastasis of the gastric carcinoid tumor. B H&E, ϫ50; C H&E, ϫ20; D H&E, ϫ100; E H&E, ϫ100
respectively. There are some discrepancies in the histology and biological behavior of gastric carcinoid tumors between the West and Japan.
According to Soga [15] , gastric carcinoid tumors are classified into five types, from A to E, according to their histological growth patterns. Types A and B and some of type E are regarded as ordinary or typical carcinoid tumors, and types C and D and some of type E as atypical carcinoid tumors. The overall metastatic rate was reported to be 33.2%, and there was a significant difference between the typical and atypical groups (29.9% vs 73.5%).
In our patient, the carcinoid tumor consisted of microlobular-trabecular aggregates formed by regularly distributed regular monomorphic nuclei (type B according to Soga [15] ). Regardless of whether it was a typical carcinoid, however, it was a sporadic tumor with regional lymph node metastasis in the absence of hypergastrinemia, corresponding to Rindi's type III.
The metastatic rates of gastric carcinoid tumors confined within the mucosal, submucosal, and muscular layers were 7.5%, 13.2%, and 44.8%, and the metastatic rates by tumor size (Ϲ10 mm, 11-20 mm, and Ͼ20 mm in diameter) were 8.2%, 15.1%, and 52.6%, respectively. Therefore, for gastric carcinoid tumors over 11 mm in diameter, or those showing massive involvement of the submucosa, en-bloc surgical resection with lymph node dissection is required, while tumors less than 10 mm in diameter could be managed by endoscopic excision, followed by endoscopic surveillance at 6-month intervals.
In mucosal gastric cancer, limited lymph node dissection with local gastrectomy is appropriate to preserve the stomach function and a reasonably good quality of life [16] . In our patient, a small sporadic carcinoid (Ϲ10 mm in diameter) and early carcinoma of the stomach were evident.
There was no preoperative evidence of lymph node metastasis. Thus, segmental gastrectomy with perigastric lymph node dissection was performed. Synchronous malignancy was found in 12% of the patients with gastric carcinoid tumors reported in the literature, and nearly half of them were found to have early gastric carcinoma. Of these patients with synchronous malignancy, almost half exhibited the coexistence of two histological elements, carcinoid tumor and adenocarcinoma, in single neoplastic nodules, as either composite or collision tumors [15] .
Previous studies showed that type III tumors were mostly solitary, larger than 11 mm in 25%-70% of patients, and deeply invasive (infiltrating into the muscular layer and serosa in 77% of patients). Accordingly, these tumors have a high metastatic tendency (36%-39%) [11, 17, 18] .
Recently, we have found some reports in the literature describing type III tumors that were less than 10 mm in diameter with regional lymph node metastasis [19, 20] . Clinicopathological analysis showed that such type III tumors had a higher Ki67 index (suggesting high proliferation of tumor cells) and greater p53 accumulation (suggesting mutational transformation) than type I and II tumors [21, 22] . From these findings, type III gastric carcinoids can be regarded as having considerable malignant potential, regardless of their size [23, 24] .
We have described a case of small, sporadic gastric carcinoid tumor with regional lymph node metastasis, corresponding to Rindi's type III. We emphasize that type III gastric carcinoid tumors require aggressive surgical treatment with lymph node dissection, even if they are smaller than 10 mm in diameter.
